Volume | 904,349 |
|
|||||
News | - | ||||||
Day High | 4.995 | Low High |
|||||
Day Low | 4.845 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Savara Inc | SVRA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.88 | 4.845 | 4.995 | 4.98 | 4.85 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6,037 | 904,349 | $ 4.91 | $ 4,443,780 | - | 1.63 - 5.70 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:54:27 | 17 | $ 4.99 | USD |
Savara Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
687.98M | 138.15M | - | 0 | -54.7M | -0.40 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Savara News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SVRA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.92 | 4.995 | 4.76 | 4.86 | 474,706 | 0.1123 | 2.28% |
1 Month | 5.19 | 5.70 | 4.52 | 5.08 | 768,310 | -0.1577 | -3.04% |
3 Months | 4.365 | 5.70 | 4.115 | 4.90 | 815,172 | 0.6673 | 15.29% |
6 Months | 3.72 | 5.70 | 3.115 | 4.48 | 744,407 | 1.31 | 35.28% |
1 Year | 2.02 | 5.70 | 1.63 | 3.95 | 620,039 | 3.01 | 149.12% |
3 Years | 1.66 | 5.70 | 1.02 | 2.61 | 506,371 | 3.37 | 203.15% |
5 Years | 8.05 | 11.96 | 0.69 | 2.69 | 679,620 | -3.02 | -37.49% |
Savara Description
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). |